Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03947619 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial

Study acronym: DTU-STEMI
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Secondary endpoints: 3 to 9v35
  2. Study sites: 64 to 63v34
  3. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 668 to confirmed 527
    • Study sites: 83 to 64
    • Primary completion date changed from estimate of Nov 2024 to Sep 4, 2024
    v33
  4. Study sites: 79 to 83
    • Eligibility criteria expanded, about 34 words
    v32
  5. Study sites: 78 to 79v31
Show 29 earlier versionsHide 29 earlier versions
  1. Study sites revised (78)v30
  2. Site details revised at 4 of 78 sitesv29
  3. Site details revised at 3 of 78 sitesv28
  4. Study sites: 71 to 78v27
  5. Study sites: 70 to 71
    • Eligibility criteria expanded, about 3 words
    v26
  6. Primary completion date: Oct 2023 to Nov 2024
    • Study sites: 58 to 70
    • Study completion date: Oct 2027 to Oct 2030
    • Eligibility criteria expanded, about 17 words
    v25
  7. Site details revised at 1 of 58 sitesv24
  8. Site details revised at 1 of 58 sitesv23
  9. Study sites: 57 to 58v22
  10. Study sites: 54 to 57v21
  11. Site details revised at 2 of 54 sitesv20
  12. Study sites: 52 to 54v19
  13. Site details revised at 1 of 52 sitesv18
  14. Study sites: 49 to 52v17
  15. Study sites: 50 to 49v16
  16. Study sites: 49 to 50
    • Eligibility criteria expanded, about 12 words
    v15
  17. Study sites: 28 to 49v14
  18. Study sites: 27 to 28v13
  19. Study sites: 26 to 27v12
  20. Study sites: 24 to 26v11
  21. Study sites: 23 to 24v10
  22. Study sites: 25 to 23v9
  23. Site details revised at 2 of 25 sitesv8
  24. Site details revised at 1 of 25 sitesv7
  25. Trial status: Active, Not Recruiting to Recruiting
    • Enrollment target: 16 to 668
    • Site details revised at 25 of 25 sites
    v6
  26. Enrollment target: estimated 688 to confirmed 16
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 25 of 25 sites
    v5
  27. Secondary endpoints revised (3)
    • Site details revised at 2 of 25 sites
    • Eligibility criteria expanded, about 2 words
    v4
  28. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Oct 2019 to Dec 12, 2019
    • Site details revised at 25 of 25 sites
    v3
  29. Study sites: 3 to 25v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Abiomed Inc.
13 trials monitored
See 1 trial at risk
Heart Disease
8,786 trials monitored
See 412 trials at risk
The purpose of this research study is to evaluate whether using the the IMPELLA® CP System temporary circulatory assist device for 30 minutes prior to a catheterization procedure has the potential to reduce the damage to the heart caused by a heart attack, compared to the current standard of care.
Trial Details
NCT Number NCT03947619
Lead Sponsor Abiomed Inc.
Conditions
(from sponsor)		 ST Elevation (STEMI) Myocardial Infarction of Anterior Wall
Related terms ST Elevation Myocardial Infarction
Enrollment 527 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov